{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-09-02T12:22:59.831537+00:00",
  "news": [
    {
      "title": "Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPOXhjWVBlMGh4a0RDMkFZZTBwdnkzUlhtOGhnejlMRUlwWEg3YUFrZzFMMlo3bW5rV3FOLWpiUFBiZWJmekxGZ1B2MXJ1UXNkQVJxMHdORm1yQVFKNE9GOVJWcm9oUjNKQVVXbzZCRjNQS3otYXNtbEowb2RYajBrRVVoR0ZJRk5I?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPOXhjWVBlMGh4a0RDMkFZZTBwdnkzUlhtOGhnejlMRUlwWEg3YUFrZzFMMlo3bW5rV3FOLWpiUFBiZWJmekxGZ1B2MXJ1UXNkQVJxMHdORm1yQVFKNE9GOVJWcm9oUjNKQVVXbzZCRjNQS3otYXNtbEowb2RYajBrRVVoR0ZJRk5I?oc=5\" target=\"_blank\">Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-02T07:29:44+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Will Amgen Inc. benefit from macro trends - Market Weekly Review & Fast Entry High Yield Stock Tips - Newser",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBoUEVQNGxvTUk0czIzdmEzMThENXZxVWJ6R1BZdFBBNkcwU1VqWWp3TDJ0RU9YTGZYR1Y3MFhUZkVCOENFTjlmUUJpR3RTblhsTlAwUU5ObDFCbnV1cWpRcHp0X2psRGp2Sks3RldwaVZWLS1xRllfM0kwbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTFBoUEVQNGxvTUk0czIzdmEzMThENXZxVWJ6R1BZdFBBNkcwU1VqWWp3TDJ0RU9YTGZYR1Y3MFhUZkVCOENFTjlmUUJpR3RTblhsTlAwUU5ObDFCbnV1cWpRcHp0X2psRGp2Sks3RldwaVZWLS1xRllfM0kwbw?oc=5\" target=\"_blank\">Will Amgen Inc. benefit from macro trends - Market Weekly Review & Fast Entry High Yield Stock Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-09-02T10:30:55+00:00",
      "source": "Newser"
    },
    {
      "title": "Amgen Inc. $AMGN Holdings Trimmed by Tema Etfs LLC - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNZDA1Zy1pZnlySFlKRU04RWZtZ1Q4aEs2cUQtVVFucld2cGx2TEx4WjdIbUowWmVBb0JDb1RiT1hlTDN4aHpSZURoRVM2Tk5mYkp0M1NTOFZwVmFDTlN2OXhlMjZvSWFDRXc1TVk3QzZXVWg3WE0xcEcxV3VHOFptV1RrdnI3RlUyYm5xbVVRQU9VRHQ2Y0tiZkxnNmprcGhUQURUZ0w4cy1RaDBsTlFr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNZDA1Zy1pZnlySFlKRU04RWZtZ1Q4aEs2cUQtVVFucld2cGx2TEx4WjdIbUowWmVBb0JDb1RiT1hlTDN4aHpSZURoRVM2Tk5mYkp0M1NTOFZwVmFDTlN2OXhlMjZvSWFDRXc1TVk3QzZXVWg3WE0xcEcxV3VHOFptV1RrdnI3RlUyYm5xbVVRQU9VRHQ2Y0tiZkxnNmprcGhUQURUZ0w4cy1RaDBsTlFr?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Holdings Trimmed by Tema Etfs LLC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-09-02T10:37:40+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "2025 Amgen Irish Open prize money: How much is up for grabs at The K Club? - Today's Golfer",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNZWFNemV4YkxCd0V1MHJxTHZZY2ZRTF9aZ3M4ZjZzYnBaYlplQThSMlBhblhCaDNlSVU2VkpaOEp4RnBDR2FSV1JHNkp0T3Bfd3Z6aTd2RzQ5S1JDVHBaTnFudUdXdmpnbzktNm83S3JOaV9wQVVsQjlLS1o1YXBuT2hjYXhUeWRGX3o1dGFn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNZWFNemV4YkxCd0V1MHJxTHZZY2ZRTF9aZ3M4ZjZzYnBaYlplQThSMlBhblhCaDNlSVU2VkpaOEp4RnBDR2FSV1JHNkp0T3Bfd3Z6aTd2RzQ5S1JDVHBaTnFudUdXdmpnbzktNm83S3JOaV9wQVVsQjlLS1o1YXBuT2hjYXhUeWRGX3o1dGFn?oc=5\" target=\"_blank\">2025 Amgen Irish Open prize money: How much is up for grabs at The K Club?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Today's Golfer</font>",
      "published": "2025-09-02T11:07:42+00:00",
      "source": "Today's Golfer"
    },
    {
      "title": "Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million - Medical Dialogues",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Dialogues</font>",
      "published": "2025-09-02T06:15:40+00:00",
      "source": "Medical Dialogues"
    },
    {
      "title": "Meet One Amgen Scientist Who Helped Crack the “Undruggable” KRAS Code - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnYyVDJWSXAxS1hMZHVBa0lJY0RpZE91ZnJnOHpUdU5pa0JseVpMY0tCYkY2Q0NyeGhVQklfSFJqaWxaT1NMVy1RUjhybUh1WDVxTkxwcVJaak00SXQyVGttdEVpSGRJSDFaWUQybGdtbVpSSjBZbG8xMEZHcEhfblEwdWFKRHJza3VQajNQSkRUdE53ZWZ5TU9vWVowTlBPQTdvWlhKUnA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnYyVDJWSXAxS1hMZHVBa0lJY0RpZE91ZnJnOHpUdU5pa0JseVpMY0tCYkY2Q0NyeGhVQklfSFJqaWxaT1NMVy1RUjhybUh1WDVxTkxwcVJaak00SXQyVGttdEVpSGRJSDFaWUQybGdtbVpSSjBZbG8xMEZHcEhfblEwdWFKRHJza3VQajNQSkRUdE53ZWZ5TU9vWVowTlBPQTdvWlhKUnA?oc=5\" target=\"_blank\">Meet One Amgen Scientist Who Helped Crack the “Undruggable” KRAS Code</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-08-28T18:17:26+00:00",
      "source": "Amgen"
    },
    {
      "title": "Here’s What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A “Banshee” - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifkFVX3lxTE9BT29qQjhkcWY4Y1JreVN6cjBFNlc2c1pmMzlKYWY4OTAtVjJPOGNPM0V2MHVUbUNtYWVOTXJzQ2o5TXdtRGVLUmV6M1Fqd19teFNvUVpHckZfeFhXa24xeWIxdTNPbjlKcXpBM0U2VkdZdWdzbXFMQUFHU19zZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifkFVX3lxTE9BT29qQjhkcWY4Y1JreVN6cjBFNlc2c1pmMzlKYWY4OTAtVjJPOGNPM0V2MHVUbUNtYWVOTXJzQ2o5TXdtRGVLUmV6M1Fqd19teFNvUVpHckZfeFhXa24xeWIxdTNPbjlKcXpBM0U2VkdZdWdzbXFMQUFHU19zZw?oc=5\" target=\"_blank\">Here’s What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A “Banshee”</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-01T20:59:31+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Inc. $AMGN Shares Bought by CreativeOne Wealth LLC - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOb3g2ay1zUmlGZXVfWTN4YW4tckRfQlMzRGtsZGtDRzhnQnlLNE56ZWxrdVNWMjN6WGlKOWtpTkd0R19MUjNsZnFfWkZKbVowcHp6cVNGTVBUclQ4ZnVuVm5nM1JxVEM4dmVRQjZpZkhuTVhKMG9xSjFzc2UxZU9sSzFjZFN3SjdUb19JcEZOUDJMWkU4RE5PNWFNMzVJblJkalRycml5WTMxZ3NyeTBhYVJkdUNkSVBjTlFyS0tlSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxOb3g2ay1zUmlGZXVfWTN4YW4tckRfQlMzRGtsZGtDRzhnQnlLNE56ZWxrdVNWMjN6WGlKOWtpTkd0R19MUjNsZnFfWkZKbVowcHp6cVNGTVBUclQ4ZnVuVm5nM1JxVEM4dmVRQjZpZkhuTVhKMG9xSjFzc2UxZU9sSzFjZFN3SjdUb19JcEZOUDJMWkU4RE5PNWFNMzVJblJkalRycml5WTMxZ3NyeTBhYVJkdUNkSVBjTlFyS0tlSQ?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Shares Bought by CreativeOne Wealth LLC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-09-02T10:39:36+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "How Does Amgen Stack Up After Humira Biosimilar Launch and Recent Price Swings? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">How Does Amgen Stack Up After Humira Biosimilar Launch and Recent Price Swings?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-08-26T10:21:03+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-29",
      "close": 287.7099914550781
    },
    "history": [
      {
        "date": "2025-08-21",
        "close": 293.3800048828125
      },
      {
        "date": "2025-08-22",
        "close": 293.7200012207031
      },
      {
        "date": "2025-08-25",
        "close": 288.4700012207031
      },
      {
        "date": "2025-08-26",
        "close": 289.5799865722656
      },
      {
        "date": "2025-08-27",
        "close": 287.9700012207031
      },
      {
        "date": "2025-08-28",
        "close": 285.6099853515625
      },
      {
        "date": "2025-08-29",
        "close": 287.7099914550781
      }
    ],
    "name": "Amgen Inc."
  }
}